- Home
- BRX vs CORT Comparison
BRX vs CORT Comparison
Compare BRX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRX | CORT |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.6B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRX | CORT |
|---|---|---|
| Price | $26.25 | $83.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | $29.82 | ★ $130.20 |
| AVG Volume (30 Days) | ★ 2.9M | 999.2K |
| Earning Date | 02-09-2026 | 11-04-2025 |
| Dividend Yield | ★ 4.68% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.08 | 0.87 |
| Revenue | ★ $1,346,289,000.00 | $741,172,000.00 |
| Revenue This Year | $7.62 | $23.96 |
| Revenue Next Year | $4.41 | $43.40 |
| P/E Ratio | ★ $24.35 | $94.62 |
| Revenue Growth | 5.75 | ★ 17.92 |
| 52 Week Low | $22.29 | $49.00 |
| 52 Week High | $28.61 | $117.33 |
Technical Indicators
Market Signals| Indicator | BRX | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 54.70 | 52.30 |
| Support Level | $25.58 | $80.38 |
| Resistance Level | $26.41 | $85.34 |
| Average True Range (ATR) | 0.40 | 3.46 |
| MACD | 0.13 | -0.44 |
| Stochastic Oscillator | 90.03 | 44.83 |
Price Performance
Historical ComparisonAbout BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.